Stay updated on Moderna Press Releases
Sign up to get notified when there's something new on the Moderna Press Releases page.

Latest updates to the Moderna Press Releases page
- ChecktodayChange DetectedStock data at the top of the page is updated with current values, and the News and Blog Posts section gains several new items for May–June 2026, including conference presentations, publications, and regulatory updates.SummaryDifference8%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedOn the Press Releases page, the News and Blog Posts list is replaced with a 'Loading...' indicator, hiding the previously visible posts. This suggests content is being loaded asynchronously and is not currently visible to the user.SummaryDifference5%

- Check22 days agoChange DetectedA new press release item announcing Moderna's TIME recognition (May 12, 2026) was added to the News page; an older press release about patent litigation resolution with Arbutus/Genevant (March 3, 2026) was removed.SummaryDifference1%

- Check29 days agoChange DetectedTwo items were added to the page: a $0.00 value and a 'Loading...' indicator; a substantial set of press release items (headlines and dates) were removed from the listing, reducing the amount of news visible to users.SummaryDifference6%

- Check36 days agoChange DetectedThe header stock quote updated to show Moderna's latest price and volume, changing from $54.85 / 963.96K to $46.82 / 2.16M, reflecting the page's live market data.SummaryDifference0.7%

- Check43 days agoChange DetectedUpdated the press releases feed by removing several February 2026 announcements and adding new entries dated April 21, 2026 and April 17, 2026 covering a Phase 3 study initiation, upcoming conference presentations, and European Commission marketing authorization for mCOMBRIAX.SummaryDifference6%

Stay in the know with updates to Moderna Press Releases
Enter your email address, and we'll notify you when there's something new on the Moderna Press Releases page.